Our newest publication on Macromolecular (pro)drugs with concurrent direct activity against the hepatitis C virus and inflammation has been published in Journal of Controlled Release…
Our newest publication on utilizing self-immolative linker chemistry to construct antiviral macromolecular prodrugs has been published in Chemical Communications.
Our newest efforts on fighting hepatitis C and HIV with a single formulation have been published in Chemical Science.
Our research on antiviral polymer therapeutics has been highlighted on the back cover of Advanced Healthcare Materials.
Using self-immolative linker chemistry we were able to show that “Highly Active Macromolecular Prodrugs Inhibit Expression of the Hepatitis C Virus Genome in the Host…
Our newest review on “Macromolecular (pro)drugs in antiviral research” has just been published in Polymer Chemistry.
Our newest publication on “Enzyme Prodrug Therapy Engineered into Biomaterials” was published in Advanced Functional Materials.
Our recent publication available in “Advanced Healthcare Materials” focuses on identifying potent (pro)drugs against HIV through parallel automated synthesis.
Our recent work on macromolecular prodrugs of ribavirin has been featured on the front cover of Macromolecular Bioscience.
Our newest publication entitled “Biocatalytic polymer thin films: Optimization of the multilayered architecture towards in situ synthesis of anti-proliferative drugs” has been published in Nanoscale.